Your browser doesn't support javascript.
loading
Differences in HIV type 1 neutralization breadth in 2 geographically distinct cohorts in Africa.
Bandawe, Gama P; Moore, Penny L; Werner, Lise; Gray, Elin S; Sheward, Daniel J; Madiga, Maphuti; Nofemela, Andile; Thebus, Ruwayhida; Marais, Jinny C; Maboko, Leonard; Abdool Karim, Salim S; Hoelscher, Michael; Morris, Lynn; Williamson, Carolyn.
Afiliação
  • Bandawe GP; Institute of Infectious Diseases and Molecular Medicine Division of Medical Virology, University of Cape Town.
  • Moore PL; Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services School of Pathology, University of the Witwatersrand, Johannesburg Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
  • Werner L; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
  • Gray ES; Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services.
  • Sheward DJ; Institute of Infectious Diseases and Molecular Medicine Division of Medical Virology, University of Cape Town.
  • Madiga M; Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services.
  • Nofemela A; Institute of Infectious Diseases and Molecular Medicine Division of Medical Virology, University of Cape Town.
  • Thebus R; Institute of Infectious Diseases and Molecular Medicine Division of Medical Virology, University of Cape Town.
  • Marais JC; Institute of Infectious Diseases and Molecular Medicine Division of Medical Virology, University of Cape Town.
  • Maboko L; NIMR-Mbeya Medical Research Center, Tanzania.
  • Abdool Karim SS; Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
  • Hoelscher M; Department of Infectious Diseases and Tropical Medicine, Klinikum of Ludwig Maximilians University German Center for Infection Research, Partner Site Munich, Germany.
  • Morris L; Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services School of Pathology, University of the Witwatersrand, Johannesburg Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
  • Williamson C; Institute of Infectious Diseases and Molecular Medicine Division of Medical Virology, University of Cape Town National Health Laboratory Services, Cape Town Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa.
J Infect Dis ; 211(9): 1461-6, 2015 May 01.
Article em En | MEDLINE | ID: mdl-25398460
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / HIV-1 / Anticorpos Neutralizantes Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-HIV / Infecções por HIV / HIV-1 / Anticorpos Neutralizantes Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: Africa Idioma: En Ano de publicação: 2015 Tipo de documento: Article